Pyridam Farma Tbk PT
IDX:PYFA
Pyridam Farma Tbk PT
IDX:PYFA
Price:
206
IDR
-4.63%
Market Closed
Market Cap:
2.3T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
PYFA Alert
Pyridam Farma Tbk PT
206
-10 (-4.63%)
| 52 Week Range |
89
1 350
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Pyridam Farma Tbk PT
Income Statement
Earnings Waterfall
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
|
Revenue
|
1.3T
IDR
|
|
Cost of Revenue
|
-975.6B
IDR
|
|
Gross Profit
|
367.9B
IDR
|
|
Operating Expenses
|
-495.7B
IDR
|
|
Operating Income
|
-127.8B
IDR
|
|
Other Expenses
|
-126.2B
IDR
|
|
Net Income
|
-254B
IDR
|
Income Statement
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
Currency: IDR
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
218 897
N/A
|
222 302
+2%
|
221 210
0%
|
224 602
+2%
|
220 070
-2%
|
217 844
-1%
|
215 016
-1%
|
221 917
+3%
|
217 394
-2%
|
216 952
0%
|
215 873
0%
|
210 135
-3%
|
225 293
+7%
|
223 002
-1%
|
235 944
+6%
|
239 267
+1%
|
240 126
+0%
|
250 446
+4%
|
249 404
0%
|
248 913
0%
|
249 644
+0%
|
247 115
-1%
|
262 331
+6%
|
247 321
-6%
|
257 674
+4%
|
277 398
+8%
|
315 777
+14%
|
378 335
+20%
|
488 496
+29%
|
630 530
+29%
|
685 557
+9%
|
715 132
+4%
|
775 078
+8%
|
715 425
-8%
|
707 846
-1%
|
721 928
+2%
|
684 977
-5%
|
702 068
+2%
|
688 841
-2%
|
795 774
+16%
|
1 343 423
+69%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(80 260)
|
(80 959)
|
(78 344)
|
(77 868)
|
(78 675)
|
(79 860)
|
(80 867)
|
(83 951)
|
(80 873)
|
(81 636)
|
(80 872)
|
(82 798)
|
(87 558)
|
(88 027)
|
(94 280)
|
(94 471)
|
(94 488)
|
(99 342)
|
(99 525)
|
(102 772)
|
(107 098)
|
(106 912)
|
(111 191)
|
(100 252)
|
(105 065)
|
(113 508)
|
(135 771)
|
(175 501)
|
(242 657)
|
(385 949)
|
(428 550)
|
(455 346)
|
(546 383)
|
(464 580)
|
(461 452)
|
(465 389)
|
(394 574)
|
(406 752)
|
(407 840)
|
(490 599)
|
(975 557)
|
|
| Gross Profit |
138 637
N/A
|
141 343
+2%
|
142 865
+1%
|
146 734
+3%
|
141 395
-4%
|
137 984
-2%
|
134 149
-3%
|
137 964
+3%
|
136 520
-1%
|
135 316
-1%
|
135 002
0%
|
127 339
-6%
|
137 735
+8%
|
134 976
-2%
|
141 664
+5%
|
144 796
+2%
|
145 639
+1%
|
151 104
+4%
|
149 879
-1%
|
146 141
-2%
|
142 546
-2%
|
140 203
-2%
|
151 140
+8%
|
147 069
-3%
|
152 609
+4%
|
163 890
+7%
|
180 005
+10%
|
202 834
+13%
|
245 839
+21%
|
244 581
-1%
|
257 007
+5%
|
259 786
+1%
|
228 695
-12%
|
250 845
+10%
|
246 393
-2%
|
256 539
+4%
|
290 403
+13%
|
295 316
+2%
|
281 001
-5%
|
305 175
+9%
|
367 866
+21%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(126 768)
|
(131 470)
|
(132 945)
|
(135 274)
|
(130 824)
|
(127 435)
|
(124 823)
|
(127 406)
|
(125 631)
|
(125 489)
|
(124 924)
|
(119 561)
|
(125 239)
|
(123 533)
|
(130 349)
|
(133 388)
|
(135 757)
|
(137 566)
|
(135 347)
|
(131 806)
|
(127 833)
|
(125 971)
|
(133 855)
|
(128 363)
|
(138 881)
|
(132 490)
|
(131 895)
|
(146 763)
|
(173 189)
|
(193 468)
|
(211 323)
|
(197 494)
|
119 892
|
94 565
|
90 609
|
48 817
|
(274 305)
|
(293 558)
|
(311 607)
|
(359 835)
|
(495 652)
|
|
| Selling, General & Administrative |
(125 581)
|
(130 205)
|
(130 830)
|
(133 996)
|
(129 632)
|
(125 737)
|
(123 264)
|
(126 006)
|
(123 490)
|
(122 266)
|
(122 028)
|
(116 282)
|
(122 378)
|
(120 316)
|
(126 273)
|
(129 470)
|
(129 135)
|
(136 208)
|
(135 927)
|
(132 972)
|
(133 282)
|
(127 983)
|
(135 420)
|
(130 053)
|
(138 220)
|
(132 863)
|
(130 554)
|
(143 574)
|
(169 919)
|
(211 762)
|
(226 518)
|
(236 614)
|
(267 200)
|
(262 675)
|
(265 818)
|
(279 535)
|
(247 035)
|
(272 079)
|
(287 733)
|
(309 018)
|
(367 394)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(573)
|
0
|
0
|
(9 859)
|
(11 280)
|
(24 664)
|
(28 240)
|
(24 989)
|
(17 765)
|
(17 787)
|
(19 081)
|
(16 906)
|
|
| Depreciation & Amortization |
(3 664)
|
(3 759)
|
(4 197)
|
(3 618)
|
(3 392)
|
(2 900)
|
(2 107)
|
(2 158)
|
(2 580)
|
(2 827)
|
(2 947)
|
(2 945)
|
(2 521)
|
(2 844)
|
(2 961)
|
(2 668)
|
(2 503)
|
(1 758)
|
(1 258)
|
(1 366)
|
(1 239)
|
(1 299)
|
(1 538)
|
(1 568)
|
(1 763)
|
(1 477)
|
(2 827)
|
(4 169)
|
(5 861)
|
(7 641)
|
(8 052)
|
(8 631)
|
(10 103)
|
(12 478)
|
(13 085)
|
(15 111)
|
(13 189)
|
(13 302)
|
(14 776)
|
(25 918)
|
(35 712)
|
|
| Other Operating Expenses |
2 478
|
2 494
|
2 081
|
2 339
|
2 198
|
1 201
|
546
|
757
|
439
|
(395)
|
51
|
(334)
|
(340)
|
(372)
|
(1 117)
|
(1 250)
|
(4 119)
|
399
|
1 839
|
2 532
|
6 687
|
3 311
|
3 103
|
3 259
|
1 102
|
1 850
|
1 486
|
980
|
2 592
|
26 508
|
23 247
|
47 752
|
407 054
|
380 998
|
394 176
|
371 703
|
10 907
|
9 589
|
8 690
|
(5 819)
|
(75 640)
|
|
| Operating Income |
11 869
N/A
|
9 873
-17%
|
9 920
+0%
|
11 459
+16%
|
10 570
-8%
|
10 549
0%
|
9 326
-12%
|
10 559
+13%
|
10 889
+3%
|
9 827
-10%
|
10 077
+3%
|
7 776
-23%
|
12 495
+61%
|
11 443
-8%
|
11 313
-1%
|
11 407
+1%
|
9 881
-13%
|
13 538
+37%
|
14 532
+7%
|
14 335
-1%
|
14 712
+3%
|
14 231
-3%
|
17 285
+21%
|
18 706
+8%
|
13 728
-27%
|
31 401
+129%
|
48 110
+53%
|
56 071
+17%
|
72 650
+30%
|
51 113
-30%
|
45 684
-11%
|
62 292
+36%
|
348 588
+460%
|
345 410
-1%
|
337 002
-2%
|
305 356
-9%
|
16 098
-95%
|
1 758
-89%
|
(30 606)
N/A
|
(54 659)
-79%
|
(127 786)
-134%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(6 038)
|
(5 720)
|
(6 394)
|
(6 337)
|
(6 193)
|
(5 982)
|
(4 345)
|
(2 954)
|
(1 560)
|
(3 178)
|
(3 178)
|
(3 205)
|
(3 270)
|
(2 363)
|
(2 685)
|
(3 364)
|
(4 153)
|
(2 750)
|
(3 052)
|
(2 995)
|
(2 813)
|
(2 505)
|
(2 413)
|
(2 098)
|
(1 897)
|
(1 893)
|
(10 013)
|
(18 738)
|
(28 100)
|
(41 467)
|
(47 310)
|
(59 096)
|
(76 921)
|
(75 428)
|
(90 023)
|
(88 971)
|
(82 156)
|
(84 344)
|
(87 718)
|
(92 932)
|
(111 882)
|
|
| Non-Reccuring Items |
519
|
321
|
271
|
205
|
104
|
312
|
515
|
654
|
811
|
692
|
757
|
659
|
599
|
620
|
983
|
1 169
|
1 273
|
971
|
385
|
264
|
476
|
1 050
|
972
|
847
|
15 012
|
554
|
499
|
518
|
(14 057)
|
622
|
1 060
|
1 325
|
1 252
|
726
|
292
|
242
|
134
|
44
|
3 377
|
32
|
204
|
|
| Total Other Income |
(1)
|
(263)
|
(264)
|
(263)
|
(263)
|
(324)
|
(1 255)
|
(2 011)
|
(2 716)
|
(288)
|
(126)
|
(64)
|
197
|
(101)
|
452
|
1 050
|
1 520
|
(442)
|
(251)
|
(202)
|
(239)
|
(257)
|
(249)
|
(217)
|
(246)
|
(419)
|
(475)
|
(472)
|
(546)
|
(1 456)
|
(1 446)
|
(1 448)
|
(1 388)
|
(7 627)
|
(427)
|
(458)
|
(460)
|
(705)
|
(638)
|
(2 412)
|
(12 316)
|
|
| Pre-Tax Income |
6 349
N/A
|
4 211
-34%
|
3 533
-16%
|
5 064
+43%
|
4 218
-17%
|
4 555
+8%
|
4 241
-7%
|
6 248
+47%
|
7 424
+19%
|
7 053
-5%
|
7 531
+7%
|
5 167
-31%
|
10 022
+94%
|
9 599
-4%
|
10 063
+5%
|
10 262
+2%
|
8 521
-17%
|
11 317
+33%
|
11 613
+3%
|
11 402
-2%
|
12 137
+6%
|
12 519
+3%
|
15 595
+25%
|
17 238
+11%
|
26 598
+54%
|
29 642
+11%
|
38 122
+29%
|
37 379
-2%
|
29 948
-20%
|
8 811
-71%
|
(2 012)
N/A
|
3 074
N/A
|
271 531
+8 734%
|
263 080
-3%
|
246 844
-6%
|
216 170
-12%
|
(66 383)
N/A
|
(83 248)
-25%
|
(115 585)
-39%
|
(149 971)
-30%
|
(251 780)
-68%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(2 016)
|
(1 550)
|
(1 422)
|
(1 569)
|
(1 264)
|
(1 468)
|
(1 331)
|
(1 864)
|
(2 213)
|
(1 907)
|
(2 023)
|
(1 438)
|
(2 592)
|
(2 472)
|
(2 611)
|
(2 659)
|
(2 218)
|
(2 870)
|
(2 917)
|
(2 896)
|
(3 066)
|
(3 176)
|
(3 772)
|
(3 964)
|
(6 059)
|
(7 538)
|
(9 532)
|
(9 606)
|
(8 000)
|
(3 332)
|
(867)
|
333
|
6 988
|
12 392
|
13 811
|
13 311
|
7 348
|
(1 979)
|
(2 636)
|
(3 059)
|
(2 206)
|
|
| Income from Continuing Operations |
4 334
|
2 661
|
2 112
|
3 495
|
2 954
|
3 087
|
2 910
|
4 384
|
5 211
|
5 146
|
5 508
|
3 730
|
7 432
|
7 127
|
7 454
|
7 604
|
6 303
|
8 447
|
8 696
|
8 505
|
9 070
|
9 343
|
11 823
|
13 275
|
20 539
|
22 104
|
28 590
|
27 773
|
21 948
|
5 479
|
(2 878)
|
3 407
|
278 519
|
275 472
|
260 655
|
229 480
|
(59 036)
|
(85 226)
|
(118 221)
|
(153 030)
|
(253 985)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
(242)
|
(248)
|
(231)
|
(222)
|
23
|
23
|
6
|
(4)
|
10 655
|
31
|
|
| Net Income (Common) |
4 334
N/A
|
2 661
-39%
|
2 112
-21%
|
3 495
+65%
|
2 954
-15%
|
3 087
+5%
|
2 910
-6%
|
4 384
+51%
|
5 211
+19%
|
5 146
-1%
|
5 508
+7%
|
3 730
-32%
|
7 432
+99%
|
7 127
-4%
|
7 454
+5%
|
7 604
+2%
|
6 303
-17%
|
8 447
+34%
|
8 696
+3%
|
8 505
-2%
|
9 070
+7%
|
9 343
+3%
|
11 823
+27%
|
13 275
+12%
|
20 539
+55%
|
22 104
+8%
|
28 590
+29%
|
27 773
-3%
|
21 948
-21%
|
5 479
-75%
|
(2 877)
N/A
|
3 165
N/A
|
278 272
+8 692%
|
275 241
-1%
|
260 433
-5%
|
229 503
-12%
|
(59 012)
N/A
|
(85 221)
-44%
|
(118 226)
-39%
|
(142 375)
-20%
|
(253 954)
-78%
|
|
| EPS (Diluted) |
8.09
N/A
|
4.97
-39%
|
3.95
-21%
|
6.54
+66%
|
5.53
-15%
|
5.77
+4%
|
5.44
-6%
|
8.19
+51%
|
9.73
+19%
|
9.62
-1%
|
10.29
+7%
|
6.97
-32%
|
13.89
+99%
|
13.32
-4%
|
13.93
+5%
|
14.21
+2%
|
11.78
-17%
|
15.79
+34%
|
16.25
+3%
|
15.9
-2%
|
16.95
+7%
|
17.46
+3%
|
22.1
+27%
|
24.81
+12%
|
38.38
+55%
|
41.31
+8%
|
53.43
+29%
|
51.9
-3%
|
41.02
-21%
|
2.2
-95%
|
-5.38
N/A
|
5.91
N/A
|
520.06
+8 700%
|
110.44
-79%
|
486.72
+341%
|
92.08
-81%
|
-23.67
N/A
|
-34.19
-44%
|
-47.44
-39%
|
-12.67
+73%
|
-22.6
-78%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
